These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1814847)
21. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro. Zinetti M; Galli G; Demitri MT; Fantuzzi G; Minto M; Ghezzi P; Alzani R; Cozzi E; Fratelli M Immunology; 1995 Nov; 86(3):416-21. PubMed ID: 8550079 [TBL] [Abstract][Full Text] [Related]
22. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock. Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827 [TBL] [Abstract][Full Text] [Related]
23. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. Netea MG; Blok WL; Kullberg BJ; Bemelmans M; Vogels MT; Buurman WA; van der Meer JW J Infect Dis; 1995 Feb; 171(2):393-9. PubMed ID: 7844376 [TBL] [Abstract][Full Text] [Related]
24. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Gatti S; Faggioni R; Echtenacher B; Ghezzi P Clin Exp Immunol; 1993 Mar; 91(3):456-61. PubMed ID: 8443968 [TBL] [Abstract][Full Text] [Related]
25. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Shalaby MR; Waage A; Aarden L; Espevik T Clin Immunol Immunopathol; 1989 Dec; 53(3):488-98. PubMed ID: 2805453 [TBL] [Abstract][Full Text] [Related]
27. Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor. Schade UF; Engel R; Jakobs D Int J Immunopharmacol; 1991; 13(5):565-71. PubMed ID: 1783470 [TBL] [Abstract][Full Text] [Related]
28. Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. Kovacs EJ; Radzioch D; Young HA; Varesio L J Immunol; 1988 Nov; 141(9):3101-5. PubMed ID: 3262679 [TBL] [Abstract][Full Text] [Related]
29. Serum amyloid A, cytokines, and corticosterone responses in germfree and conventional mice after lipopolysaccharide injection. Ikeda M; Hamada K; Sumitomo N; Okamoto H; Sakakibara B Biosci Biotechnol Biochem; 1999 Jun; 63(6):1006-10. PubMed ID: 10427685 [TBL] [Abstract][Full Text] [Related]
30. Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway. Li W; Wang X; Niu X; Zhang H; He Z; Wang Y; Zhi W; Liu F Inflammation; 2016 Apr; 39(2):786-97. PubMed ID: 26846885 [TBL] [Abstract][Full Text] [Related]
31. The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers. Bleeker MW; Netea MG; Kullberg BJ; Van der Ven-Jongekrijg J; Van der Meer JW Immunology; 1997 Aug; 91(4):548-52. PubMed ID: 9378493 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626 [TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Memon RA; Grunfeld C; Moser AH; Feingold KR Endocrinology; 1993 May; 132(5):2246-53. PubMed ID: 8477669 [TBL] [Abstract][Full Text] [Related]
34. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493. D'Souza MJ; Oettinger CW; Milton GV; Tracey KJ J Interferon Cytokine Res; 1999 Oct; 19(10):1125-33. PubMed ID: 10547152 [TBL] [Abstract][Full Text] [Related]
35. Blocking interleukin-1 receptors. Dinarello CA Int J Clin Lab Res; 1994; 24(2):61-79. PubMed ID: 7919431 [TBL] [Abstract][Full Text] [Related]
36. Acute phase protein, serum amyloid A, inhibits IL-1- and TNF-induced fever and hypothalamic PGE2 in mice. Shainkin-Kestenbaum R; Berlyne G; Zimlichman S; Sorin HR; Nyska M; Danon A Scand J Immunol; 1991 Aug; 34(2):179-83. PubMed ID: 1714101 [TBL] [Abstract][Full Text] [Related]
37. Prevention of bacterial infection and LPS-induced lethality by interleukin-1 alpha in mice. Morikage T; Mizushima Y; Yano S Tohoku J Exp Med; 1991 Jan; 163(1):47-57. PubMed ID: 2048119 [TBL] [Abstract][Full Text] [Related]
38. Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity. Benigni F; Villa P; Demitri MT; Sacco S; Sipe JD; Lagunowich L; Panayotatos N; Ghezzi P Mol Med; 1995 Jul; 1(5):568-75. PubMed ID: 8529123 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects. Urbaschek R; Urbaschek B Rev Infect Dis; 1987; 9 Suppl 5():S607-15. PubMed ID: 3317753 [TBL] [Abstract][Full Text] [Related]
40. Defective tolerance to the toxic and metabolic effects of interleukin 1. Mengozzi M; Ghezzi P Endocrinology; 1991 Mar; 128(3):1668-72. PubMed ID: 1999179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]